Category Archives: Entrepreneurs

Marc Beer the MedTech guru at Renovia Inc.

Renovia Inc., a healthcare based investment firm has only been in operation for two years as it was established on August 2016. Nevertheless, in its two years of existence, the firm has marked milestones that companies which have been in play longer than that, aren’t even close to accomplishing. Its success can be attributed to its great leaders, led by Marc Beer.

 

Profitable investments that impact the lives of others positively

 

Having been in the healthcare sector all his life, Marc Beer boasts vast experience in the field of biotechnology, pharmaceuticals and several other areas of MedTech. This has helped him identify some of the most profitable areas to venture in, and this when combined by the many networking connections he boasts, has enabled him turn many of Renovia’s goals into a reality. It’s also essential to note that these investments benefit not only him, but impact the rest of the world positively as well.

 

For instance, under his direction, and that of the other two founding members of Renovia Inc., namely; Yolanda Lorie and Ramon Iglesias, Renovia Inc developed the first pelvic training device known as Leva. The primary objective for the development of the leva device is to improve the lives of more than 250 million women who suffer from pelvic disorders such as urinary incontinence after childbirth.

 

Marc Beer does it again

 

Marc Beer has once again brought triumph to Renovia Inc. after he led the company to secure a whopping $42.3 million, during its series B round founding. Again he achieved this through his top-shelf networking abilities. Once again the funding was inclusive of A-list healthcare investment firms such as Longwood, Ascension ventures, New York perceptive advisors and many others.

 

The primary purpose of the funding is to facilitate the development of a new generation Leva device which will further curb the prevalence of pelvic disorders. The funds will also be channeled to the development of three more diagnostic and therapeutic products which again, will help shape the health industry.

 

More insight into Marc Beer

 

Marc Beer has been at the helm of medical technology for more than two years now. His innovative skills when it comes to ground-breaking biotech and pharmaceutical developments has seen him be part of multiple MedTech giants. For instance, in his over 25 years career, Marc has served as Vice president of Genzyme’s global marketing team, where he helped facilitate the launch of products that address rare diseases. He was also an executive member of Erytech Pharma’s board of directors and also worked at Abbot Pharmaceuticals.

 

Marc Beer is also the man behind Viacell, a biotech company he established in 2000. As an alumnus of The University of Miami (Oxford OH), Marc Beer has accomplished a lot, and it seems he is not done transforming the healthcare sector yet. Learnb more: https://people.equilar.com/bio/marc-beer-aegerion-pharmaceuticals-/salary/78453

 

A Glimpse of Hope to Pelvic Floor Disorder Patients

Marc Beer’s career path shows his outstanding leadership skill and commitment in the pharmaceutical field. Early 2000, he was appointed as the founding chief executive officer of ViaCell. The biotechnology company grew tremendously under his leadership managing to employ over three hundred workers. ViaCell Company mainly specializes in collecting umbilical cord blood stem cell, preserving and developing. After working for five years, Marc managed to move ViaCell Company publicly by 2005; two years later it was acquired by PerkinElmer.

 

Erytech Pharma appointed Mark as one of the boards of director members while working at ViaCell. Before he had joined ViaCell, he previously worked for the Genzyme. He used his expertise in sells and marketing in launching the company products. He has also served for many companies as founding chairman including Good Start Genetics, Minerva Neuroscience and as the advisory council of Miami University. Marc Beer is a graduate of Miami University with a bachelor of science degree.

 

His vast experience and expertise in pharmaceutical, biotechnology, innovation, and disease diagnosis were motivating factors to partner with Dr. Pulliam, Roman Iglesias, and Yolanda Lorie and started their company, Renovia. Mark shows the compassion in his duty by raising $42 million for finding the solution with regards to women health. He uses his innovation to find a product that will cure pelvic floor disorders.

 

The Pelvic floor disorders are as the result of the injury or weakening of the ligament, tissue and pelvic muscle. The condition is caused by the prolapse of the bladder, the urethra, rectum, and small intestine. Renovia Medtech Company is fully committed in research and find a product to diagnose the disorders. They estimate to reach around 250 million women across the globe. The company is looking for an exclusive way to train patient and strengthen the weak pelvic floors muscle while the patient is alone at home by investing in leva pelvic digital health system. Leva is their first product, and by April FDA approved it.

 

Leva product is visualized with technology that trains the patient to control urination. It has motion sensor technology that shows a vaginal profile of a woman when at rest or during movement, it is programmed to measure the time one requires during training, and it is easy for a patient to track and do a subsequent reading and share data using this technology. With the leva treatment, one requires no surgeries.

 

The funding from the Long wood is going to be used in developing of four products. Mark during an interview noted that the Renovia Company is appreciating the investors who willing are offering support to Boston based Medtech and it is so committed to provide treatment and change millions of lives of pelvic floor disorders patient in the world. Learn more: https://www.linkedin.com/in/marcbeer

 

Marc Beer and Pelvic Floor Disorders

Renovia Inc. is a startup organization that was founded by Marc Beer. Renovia is an organization in the pharmaceutical industry. The company will be moving forward with its new products that deal with pelvic floor disorders after it closed at $32 million Series B round. In addition to this, the company closed with another ten million in business debt. Renovia is located in Boston, and the company is coming up with several diagnostic and therapeutic products meant to cure pelvic floor disorders such as urinary incontinence. According to researchers, the disorder is affecting more than 250 million women around the globe. The first product of Renovia received approval from FDA in April. Longwood fund also joined Series B round too. Learn more: https://renoviainc.com/leadership/

 

Longwood is an organization that invests in companies that are dealing with healthcare. The organization is under Perspective Advisor in New York as well as Ascension Ventures base in Missouri. The funding will be used to create and testing four other diagnostic and therapeutic products including Leva device’s new generation. Marc Beer claimed that they were happy to have such partners who are ready to fund the shared vision to diagnose correctly, as well as treat, and enhance the lives of millions of women across the world who are suffering from pelvic floor disorders. By bringing together the company’s proprietary and innovative sensor technologies, the organization will be able to create elements with a digital health platform that will provide its clients with information about the company’s new treatment options.

 

In addition to this, the platform will allow the clients to get a better understanding of the disorders of the pelvic floor. Moreover, it will help the customers to be able to lower the costs of long-term health care. Renovia forms the first organization that Marc Beer has come up with since he left Aegerion. Marc has brought great talent to the organization since it was started in 2016. He believes that with this great team, the organization will soar high in terms of success in the coming years.

 

Marc takes his time to recruit the best of the best into his organization, a fact that gives him confidence that they will reach their goals. He believes that Renovia is the leader when it comes to the healthcare of women as well as in the digital health. Marc acknowledges the fact that there were earlier breakthroughs in peripheral vascular disease, pain management, and cardiac disorders. But there had never been such a breakthrough in women healthcare and digital healthcare until Renovia came into existence. Marc goes ahead to say that he knows that there will be more breakthroughs in the area in the future. According to Marc, all organizations require capital efficiency and resource allocation, and this is what has seen Renovia to its current state. Follow Marc Beer on LinkedIn

 

Marc Beer Supports the Treatment of Pelvic Floor Disorders

Pelvic floor dysfunction refers to the inability to tighten the pelvic floor muscles when having a bowel movement. The symptoms include urine leakage and constipation to mention a few. Treatments include biofeedback, surgery, and medication. Biofeedback allows the therapist to evaluate how the patient relaxes their pelvic muscles via special sensors after which the therapist will observe your coordination. Surgery is useful in loosening your affected pelvic floor organs if it’s rooted in rectal prolapse, a disorder that causes the rectal tissue to fall in your anal opening. In medication, your doctor will prescribe a muscle relaxer to prevent your muscles from contracting. But, most individuals suffering from pelvic floor disorders cannot access these treatment methods. Therefore, scientists, entrepreneurs, and donors have collaborated to finance the treatment. One such individual is Marc Beer. Learn more: https://www.slideshare.net/MarcBeer

 

Marc Beer’s Contribution

 

Marc Beer is the CEO of Renovia Inc. He is a talented entrepreneur with a problem-solving acumen for business. He has been transforming businesses into strong financial vehicles through strategic policies. The recent funding of $42 million for a biotechnology start-up Marc Beer co-founded has spoken about his reputation for transforming small businesses to successful companies with a reputable future. The collected funds will be used to finance the research and drug development of pelvic floor disorders since it’s an international healthcare problem that affects millions of women.

 

The Fund Raiser

 

The funds were raised by an infusion strategy that saw the start-up receive donations from various investment companies including Ascension Ventures and Longwood Fund. This donation will be used to improve the development of Revia, a fully FDA approved drug used to treat pelvic floor disorders. Marc Beer hopes that the new round of Series B Funding will catapult the company towards perfecting the diagnosis systems for pelvic floor disorders by partnering with revolutionary patient-based technologies that have valuable data. He also hopes that it will contribute to a reduced overhead cost for treating urinary incontinence.

 

Professional Experience

 

Marc Beer is a business generator, motivational speaker and the co-founder of Renovia. He combines dynamism with charisma to generate a force to improve businesses. He marshals his resources to develop startups into useful businesses. He consistently looks out for challenges to find viable solutions and opportunities for the less fortunate. Over the years, he’s garnered experience from various companies including ViaCell where he was the CEO. In his tenure, the company succeeded in stem cell research thereby earning a stellar reputation in NASQAD. The employee base grew tremendously.

 

Academic Qualifications

 

Beer is a business developer with extensive experience in sales, marketing, and pharmacy. Prior to joining the startup origination industry, he was the vice president of Genzyme, an international marketing company. He has a degree in science from Miami University.

“Marc Beer Uses Innovative Technology to Diagnose and Treat Pelvic Floor Disorders “

The age of technology has brought a significant number of technological devices that individuals can use to monitor and control their health is changing the health industry. People can now monitor their health problems in a consistent manner, which will help them to understand the characteristics of their conditions. Understanding the basic characteristics of a disorder helps the doctors or other medical physicians to provide a solution to the ailment in a simple and cost-effective strategy. Renovia Inc. is one of the technology-based medical companies that are providing advanced medical devices to monitor the health of an individual.

 

The company, which was founded in 2016 by Marc Beer and other health experts has come up with an innovative device that helps in monitoring and controlling pelvic floor disorders such as urinary inconsistency. Pelvic floor disorders are a group of rare medical conditions that are affecting a significant number of women around the world. Current statistics indicate that more than two hundred and fifty million women in the United States and other parts of the world are experiencing a medical condition that is associated with pelvic floor disorder.

 

Multiple studies continue to highlight that there has no exhaustive method of diagnosing pelvic floor disorders such as urinary inconsistency and pelvic floor pain, which has caused a large number of women to remain with untreated health problems, which can mutate to more complex health conditions such as cancer. In the worst case, many women are diagnosed with the wrong health problem, which means that they consume the wrong drugs. Therefore, there is a necessity for a company to specialize in these conditions and bring up the necessary health conditions, which will help in eliminating or controlling these conditions.

 

Marc Beer has brought one of the most innovative technological methods that will assist in diagnosing and treating pelvic floor disorders. However, the project had been interrupted by a significant lack of funds to produce the products in large quantities so that people around the world can access them with ease. Through the influence of Marc Beer, Renovia Inc. has been able to marshal funds from different sources either through donations or loans. The medical company received around $32 million from healthcare investors such as The Longwood and other interested organizations. The other remaining amount, $10 million, was secured through venture debts.

 

About Marc Beer

Marc Beer is the co-founder of Renovia Inc., a technology-based medical company that provides innovative solutions to pelvic floor disorders. Marc also acts as the Chief Executive Officer of the medical company, which he co-founded with other medical experts with the aim of eliminating or controlling the rare conditions. Pelvic floor disorders have been affecting a significant number of women around the world, without a real solution to counter the effects of these disorders. Learn more: https://www.slideshare.net/MarcBeer

 

Stem Cells Transplants could Trigger Longer Remission of Multiple Sclerosis

Multiple sclerosis is an autoimmune disease where the immune system attacks the central nervous system. Research findings indicate that there could be permanent or prolonged remission with the high doses of immunosuppressive therapy especially when it is followed by transplanting a patient’s own blood-forming stem cells. 69 percent of patients involved in a clinical trial showed positive responses five years later. These patients did not experience any progression of disability, new brain lesions or a relapse of MS symptoms. In fact, most patients did not take any MS medication after the procedure. From different research findings, it is believed that the current MS medications are not effective.

The NIAD-National Institute of Allergy and Infectious Diseases sponsored this clinical trial, HALT-MS. The researchers involved in the study made publications of their results for three years in 2014 December with their last 5-year result appearing online in February in the Neurology, which is the medical journal of the American Academy of Neurology.With the findings of the research, it is encouraging to note that a single HDIT/HCT treatment is better than prolonged MS medication. The findings continue to encourage more trials for better solutions to curb the depilating disease. MS symptoms have different variations and often include speech and motor difficulties. There is always a chronic pain and constant fatigue and weakness. The most common form of MS is the relapsing type, which is a mixture of mild and fired up symptoms. It is possible for the disease to shift and reach progressive forms, which is a worse state.

About Dr. Shiva GopalVasishta

Dr. Shiva GopalVasishta, based in Voorhees, is an experienced and highly qualified practicing neurologist. He graduated from Government Medical College in 1979 and has been practicing for over four decades now. Dr. Shiva completed his residency in Boston city hospital.Dr. Shiva specializes in psychiatry and currently works at Eastern Neurodiagnostic Associates. He accepts insurance covers for payment of his services. You, therefore, do not have any reason not to visit this expert to receive the best treatment.

Flavio Maluf: A Role Model to Budding Entrepreneurs

Eucatex is a leading multinational company that operates in the furniture and construction industry. They specialize in the manufacture of panels, acoustic ceiling material, soft and hard boards. This company has colonized the Brazilian furniture and construction market with its excellent products.

The history of Eucatex Group

Eucatex first opened its doors on November 23, 1951. At the time, it was the first company in Brazil to portray environmental conservation initiatives; the company used eucalyptus trees as raw material. The parent company of Eucatex was Americana Sawmill Americana, a company that was inaugurated in 1923, in São Paulo, Brazil.

Currently, the company is satisfying the furniture making and packaging needs of the companies in the furniture industry. The company also services the needs of big companies in the construction sector. Its other products such as doors and plates are also exported to foreign markets.

Eucatex owns three state-of-the-art factories that manufacture its products. The plant that is concerned with producing paints and varnishes operates from Salto and the plant that deals with panels and flooring options operate from Botucatu, Brazil. The third factory operates from the Municipality of Salto in Sao Paulo State. It is charged with manufacturing thin high-density fiberboard and the medium density fiberboard (FDF).

About the chair of Eucatex

Flavio Maluf, the current chair of Eucatex Group, is a renowned entrepreneur born on December 2, 1961, in Sao Paulo. He attended and successfully graduated from the Armando Alvares Penteado Foundation (FAAP) with a degree in mechanical engineering. He also attended New York University where he graduated with a degree in business administration.

Besides being the president of Eucatex, he also heads GrandFood Group which is the proprietor of Premier Pet and Golden brands of feed. Mr. Maluf is also a mentor to young entrepreneurs; he gives lectures concerning the ways through which upcoming entrepreneurs can achieve profitability and success when they internationalize their businesses.

He says that budding entrepreneurs need to study and internalize their target market in order to find the segment level that is unexploited.

Follow him on Twitter to learn more about his tips for entrepreneurs.

The Mortgage Industry Thrives Under Todd Lubar

Todd Lubar is considered to be one of the most successful mortgage industry entrepreneurs. He is a family man and currently lives in Bethsada, Maryland with his two children. He went to Side Well Friends School in 1977 and proceeded to High school at Hightstown. His entrepreneurial skill became evident during his studies at Syracuse University. Here, he was involved in a small business that helped him get through at the university. He graduated in the year 1995 having completed his studies in speech communication. His completion was followed by an employment contract with Crestar Mortgage Corporation. With this company, he worked for five years and gained experience that he used to start his private business.

Later, he got a job with Legacy Financial group and moved to Maryland. It was at this company that he got to interact with investors across the Globe. He was also in charge of mortgage banks that sought the services of the enterprise. In 2002, Lubar formed Legendary Properties LLC. The company invested in the purchase and sale of family homes. Later, the company ventured into development and the sale of apartments. Serving under Legendary properties, Lubar met with the major players in the construction trade. He also cultivated relationships with managers in banks and financial lending institutions. Later, Lubar used these connections to establish a firm foundation for his business.

In 2003, Lubar co-founded Charter Funding. Charter funding was a subsidiary of First Magnus Financial Inc. He took the role of vice president. As a result of the coexistence between these two companies, Lubar used his access to Magnus capital to further his interests.

Lubar later founded another company that majored in providing loans to organizations, unions, and people who could not get financed by conventional lenders. The availability of these customers has helped the company transact over 7000 deals since its foundation. He named the company Legendary Financial LLC.

As a result of the downward trend in the economy, the mortgage industry experienced significant problems, and drastic changes had to be made. This downward trend forced Lubar to divert his investments into other sectors. He acquired several demolition industries. He also ventured into the nightclub industry as it is considered to be an ever growing market. Finally, he eyed the waste management sector by acquiring a scrap metal recycling company. Currently, TDL global venture is run under his authority as CEO.